TY - JOUR
T1 - Evidence-Based Prevention of Preeclampsia
T2 - Commonly Asked Questions in Clinical Practice
AU - Wertaschnigg, Dagmar
AU - Reddy, Maya
AU - Mol, Ben W.J.
AU - Da Silva Costa, Fabricio
AU - Rolnik, Daniel L.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - In this review, we discuss the recent literature regarding the prevention of preeclampsia and aim to answer common questions that arise in the routine antenatal care of pregnant women. Prescription of low-dose aspirin for high-risk patients has been shown to reduce the risk of preeclampsia (PE). A daily dose between 100 and 150 mg taken in the evening should be initiated prior to 16 weeks of gestation and can be continued until delivery. Calcium supplementation seems to be advantageous but currently it is only considered for patients with poor dietary intake and high risk for PE. Recent data about heparin are still conflicting, and therefore, heparin can currently not be recommended in the prevention of PE.
AB - In this review, we discuss the recent literature regarding the prevention of preeclampsia and aim to answer common questions that arise in the routine antenatal care of pregnant women. Prescription of low-dose aspirin for high-risk patients has been shown to reduce the risk of preeclampsia (PE). A daily dose between 100 and 150 mg taken in the evening should be initiated prior to 16 weeks of gestation and can be continued until delivery. Calcium supplementation seems to be advantageous but currently it is only considered for patients with poor dietary intake and high risk for PE. Recent data about heparin are still conflicting, and therefore, heparin can currently not be recommended in the prevention of PE.
UR - http://www.scopus.com/inward/record.url?scp=85071098688&partnerID=8YFLogxK
U2 - 10.1155/2019/2675101
DO - 10.1155/2019/2675101
M3 - Review Article
C2 - 31467716
AN - SCOPUS:85071098688
VL - 2019
JO - Journal of Pregnancy
JF - Journal of Pregnancy
SN - 2090-2727
M1 - 2675101
ER -